BIOVENTUS INC. Current Foreign Tax Expense (Benefit)
BIOVENTUS INC. (BVS) reported Current Foreign Tax Expense (Benefit) of $2.86 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2026-03-05
- BIOVENTUS INC. current foreign tax expense (benefit) for fiscal 2025 was $2.86M, a 84.88% increase from fiscal 2024.
- BIOVENTUS INC. current foreign tax expense (benefit) for fiscal 2024 was $1.55M, a 39.33% increase from fiscal 2023.
- BIOVENTUS INC. current foreign tax expense (benefit) for fiscal 2023 was $1.11M, a 275.34% increase from fiscal 2022.
- BIOVENTUS INC. current foreign tax expense (benefit) for fiscal 2022 was $296.00K, a 19.35% decline from fiscal 2021.
| Period end | Current Foreign Tax Expense (Benefit) 12 month | Current Foreign Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $2.86M 10-K · filed 2026-03-05 | |
| 2024-12-31 | $1.55M 10-K · filed 2026-03-05 | |
| 2023-12-31 | $1.11M 10-K · filed 2026-03-05 | |
| 2022-12-31 | $296.00K 10-K · filed 2025-03-11 | $289.00K 10-K · filed 2023-03-31 |
| 2021-12-31 | $367.00K 10-K · filed 2024-03-12 | |
| 2020-12-31 | $707.00K 10-K · filed 2023-03-31 | |
| 2019-12-31 | $815.00K 10-K · filed 2022-03-11 |